You have 9 free searches left this month | for more free features.

Daratumumab

Showing 226 - 250 of 273

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in France (Isatuximab, ASCT)

Recruiting
  • Multiple Myeloma
  • AMIENS Cedex 1, France
  • +67 more
Mar 28, 2022

Selinexor in Relapsed or Refractory Multiple Myeloma - SEATTLE-

Recruiting
  • Multiple Myeloma
  • Wien, Austria
  • +1 more
Jul 13, 2023

Multiple Myeloma Stage I Trial in Salvador (Cyclo Thal Dex Daratumumab)

Unknown status
  • Multiple Myeloma Stage I
  • Cyclo Thal Dex Daratumumab
  • Salvador, Bahia, Brazil
    CEHON - Centro de Hematologia e Oncologia da Bahia
Jan 2, 2019

Infusion Reaction, Monoclonal Antibody Trial in Clovis (Montelukast 10 Mg Oral Tablet)

Recruiting
  • Infusion Reaction
  • Monoclonal Antibody
  • Montelukast 10 Mg Oral Tablet
  • Clovis, California
    Community Cancer Institute
Nov 8, 2021

Relapsed and/or Refractory Multiple Myeloma, Relapsed and/or Refractory Non Hodgkin Lymphoma Trial in United States (MT-0169)

Recruiting
  • Relapsed and/or Refractory Multiple Myeloma
  • Relapsed and/or Refractory Non Hodgkin Lymphoma
  • Los Angeles, California
  • +6 more
Feb 28, 2022

Multiple Myeloma Trial (Melphalan and Treosulfan, Melphalan)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Dec 5, 2022

Multiple Myeloma Trial in Warszawa, Poznan (Daratumumab 20 MG/ML [Darzalex])

Recruiting
  • Multiple Myeloma
  • Daratumumab 20 MG/ML [Darzalex]
  • Warszawa, Mazowieckie, Poland
  • +1 more
Jan 2, 2019

Multiple Myeloma Trial in Athens (Daratumumab, Ixazomib, Dexamethasone)

Unknown status
  • Multiple Myeloma
  • Daratumumab, Ixazomib, Dexamethasone
  • Athens, Attica, Greece
    General Hospital of Athens "Alexandra"
Nov 20, 2018

AL Amyloidosis Trial in France (Isatuximab)

Recruiting
  • AL Amyloidosis
  • Amiens, France
  • +14 more
Aug 9, 2022

Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

Recruiting
  • Plasma Cell Myeloma
  • Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 27, 2022

Light Chain (AL) Amyloidosis Trial in Worldwide (Birtamimab, Placebo, Standard of Care Chemotherapy)

Recruiting
  • Light Chain (AL) Amyloidosis
  • Hartford, Connecticut
  • +120 more
Aug 8, 2022

Evan Syndrome, Treatment Trial in Tianjin (Anti-CD38 antibody Injection)

Recruiting
  • Evan Syndrome
  • Treatment
  • Anti-CD38 antibody Injection
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Aug 25, 2023

Newly Diagnosed Multiple Myeloma Trial in Spain (Bortezomib, Isatuximab, Iberdomide)

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Alcalá de Henares, Madrid, Spain
  • +67 more
Sep 23, 2022

Immune Thrombocytopenia, Treatment Trial in Tianjin (CM313 Injection)

Not yet recruiting
  • Immune Thrombocytopenia
  • Treatment
  • CM313 Injection
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Jan 12, 2023

Plasma Cell Leukemia Trial in United States (Bortezomib, Daratumumab, Dexamethasone)

Withdrawn
  • Plasma Cell Leukemia
  • Duarte, California
  • +4 more
Dec 17, 2018

Relapsed/Refractory Multiple Myeloma Trial in France, United States (ISB 1342)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • ISB 1342
  • Little Rock, Arkansas
  • +21 more
May 10, 2022

Antibody-mediated Rejection Trial in Vienna, Berlin (Felzartamab, Placebo)

Recruiting
  • Antibody-mediated Rejection
  • Vienna, Austria
  • +1 more
Aug 23, 2022

Malignant Tumors Stated as Primary Lymphoid Haematopoietic Trial (Daratumumab)

Withdrawn
  • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
  • Daratumumab
  • (no location specified)
Jul 23, 2018

Refractory Plasma Cell Myeloma Trial in Jacksonville (Dexamethasone, Elotuzumab, Pomalidomide)

Suspended
  • Refractory Plasma Cell Myeloma
  • Jacksonville, Florida
    Mayo Clinic in Florida
Oct 18, 2021

AL Amyloidosis, Plasma Cell Dyscrasia Trial in Nanjing

Enrolling by invitation
  • AL Amyloidosis
  • Plasma Cell Dyscrasia
    • Nanjing, Jiangsu, China
      National Clinical Research Center of Kidney Diseases, Jinling Ho
    Jan 26, 2021

    Plasma Cell Myeloma Trial in Czechia, France, United States (Isatuximab)

    Completed
    • Plasma Cell Myeloma
    • Scottsdale, Arizona
    • +17 more
    Apr 22, 2022

    Antiphospholipid Syndrome, Thrombocytopenia Trial in Tianjin (Anti-CD38 antibody Injection)

    Recruiting
    • Antiphospholipid Syndrome
    • Thrombocytopenia
    • Anti-CD38 antibody Injection
    • Tianjin, Tianjin, China
      Chinese Academy of Medical Science and Blood Disease Hospital
    Aug 9, 2023

    Multiple Myeloma Trial in Worldwide (Daratumumab)

    Approved for marketing
    • Multiple Myeloma
    • Daratumumab
    • Phoenix, Arizona
    • +78 more
    Jan 11, 2019

    Multiple Myeloma Trial (Belantamab mafodotin (GSK2857916) anti-BCMA-immunoconjugate)

    Approved for marketing
    • Multiple Myeloma
    • Belantamab mafodotin (GSK2857916) anti-BCMA-immunoconjugate
    • (no location specified)
    Mar 9, 2021

    Relapsed, Refractory Multiple Myeloma Trial in Milwaukee (RAPA-201 Autologous T cells)

    Recruiting
    • Relapsed, Refractory Multiple Myeloma
    • RAPA-201 Autologous T cells
    • Milwaukee, Wisconsin
      Medical College of Wisconsin
    Dec 28, 2021